Riboflavin (vitamin B2) is a vitamin, also sold as a supplement, that cells use to make energy and recycle antioxidants. For adults getting enough from food, evidence for added benefit is limited and uneven. The strongest human data concern migraine prevention at amounts far above dietary needs; a blood pressure effect in carriers of one gene variant rests mainly on a single research group. Documented risks are minor. (Full Review)
| Marker | Target | Why |
|---|---|---|
| EGRAC | 1.26 or lower (optimal category) | Marker the intervention is expected to change: riboflavin status |
| Blood pressure | Below 140/90 mmHg (trial goal) | Marker the intervention may change in the 677TT genotype, and safety check alongside antihypertensive drugs |
| Plasma homocysteine | 5 to 15 µmol/L (standard reference range) | Marker the intervention may change in the 677TT genotype |
Cadence: Baseline (EGRAC, blood pressure; fasting homocysteine for 677TT or hypertension); repeat EGRAC and blood pressure at 12 to 16 weeks, then every 6 to 12 months; migraine diary monthly through the first three months.